BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 22147588)

  • 21. Differential roles of MyD88 and TRIF in hematopoietic and resident cells during murine gram-negative pneumonia.
    van Lieshout MH; Blok DC; Wieland CW; de Vos AF; van 't Veer C; van der Poll T
    J Infect Dis; 2012 Nov; 206(9):1415-23. PubMed ID: 22904341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of MyD88- and TRIF-dependent signaling pathways of Toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea.
    Youn HS; Lee JY; Saitoh SI; Miyake K; Kang KW; Choi YJ; Hwang DH
    Biochem Pharmacol; 2006 Sep; 72(7):850-9. PubMed ID: 16890209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a TLR4- and TRIF-dependent activation program of dendritic cells.
    Weighardt H; Jusek G; Mages J; Lang R; Hoebe K; Beutler B; Holzmann B
    Eur J Immunol; 2004 Feb; 34(2):558-64. PubMed ID: 14768061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GATA-3 protects against severe joint inflammation and bone erosion and reduces differentiation of Th17 cells during experimental arthritis.
    van Hamburg JP; Mus AM; de Bruijn MJ; de Vogel L; Boon L; Cornelissen F; Asmawidjaja P; Hendriks RW; Lubberts E
    Arthritis Rheum; 2009 Mar; 60(3):750-9. PubMed ID: 19248112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toll-like receptor 2/MyD88 signaling mediates zymosan-induced joint hypernociception in mice: participation of TNF-α, IL-1β and CXCL1/KC.
    Guerrero AT; Cunha TM; Verri WA; Gazzinelli RT; Teixeira MM; Cunha FQ; Ferreira SH
    Eur J Pharmacol; 2012 Jan; 674(1):51-7. PubMed ID: 22051147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of lipopolysaccharide-inducible genes by MyD88 and Toll/IL-1 domain containing adaptor inducing IFN-beta.
    Hirotani T; Yamamoto M; Kumagai Y; Uematsu S; Kawase I; Takeuchi O; Akira S
    Biochem Biophys Res Commun; 2005 Mar; 328(2):383-92. PubMed ID: 15694359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of cartilage damage by overexpression of T cell interleukin-17A in experimental arthritis in mice deficient in interleukin-1.
    Koenders MI; Lubberts E; Oppers-Walgreen B; van den Bersselaar L; Helsen MM; Kolls JK; Joosten LA; van den Berg WB
    Arthritis Rheum; 2005 Mar; 52(3):975-83. PubMed ID: 15751058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toll-like receptor 2 controls acute immune complex-driven arthritis in mice by regulating the inhibitory Fcγ receptor IIB.
    Abdollahi-Roodsaz S; Koenders MI; Walgreen B; Bolscher J; Helsen MM; van den Bersselaar LA; van Lent PL; van de Loo FA; van den Berg WB
    Arthritis Rheum; 2013 Oct; 65(10):2583-93. PubMed ID: 23860661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD300F blocks both MyD88 and TRIF-mediated TLR signaling through activation of Src homology region 2 domain-containing phosphatase 1.
    Lee SM; Kim EJ; Suk K; Lee WH
    J Immunol; 2011 Jun; 186(11):6296-303. PubMed ID: 21536801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulator of calcineurin 1 differentially regulates TLR-dependent MyD88 and TRIF signaling pathways.
    Pang Z; Junkins RD; Raudonis R; MacNeil AJ; McCormick C; Cheng Z; Lin TJ
    PLoS One; 2018; 13(5):e0197491. PubMed ID: 29799862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aging and contribution of MyD88 and TRIF to expression of TLR pathway-associated genes following stimulation with Porphyromonas gingivalis.
    Shaik-Dasthagirisaheb YB; Huang N; Weinberg EO; Shen SS; Genco CA; Gibson FC
    J Periodontal Res; 2015 Feb; 50(1):89-102. PubMed ID: 24862405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction of arthritis severity in protease-activated receptor-deficient mice.
    Yang YH; Hall P; Little CB; Fosang AJ; Milenkovski G; Santos L; Xue J; Tipping P; Morand EF
    Arthritis Rheum; 2005 Apr; 52(4):1325-32. PubMed ID: 15818676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential requirements of MyD88 and TRIF pathways in TLR4-mediated immune responses in murine B cells.
    Yanagibashi T; Nagai Y; Watanabe Y; Ikutani M; Hirai Y; Takatsu K
    Immunol Lett; 2015 Jan; 163(1):22-31. PubMed ID: 25448706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis.
    Bortolatto J; Borducchi E; Rodriguez D; Keller AC; Faquim-Mauro E; Bortoluci KR; Mucida D; Gomes E; Christ A; Schnyder-Candrian S; Schnyder B; Ryffel B; Russo M
    Clin Exp Allergy; 2008 Oct; 38(10):1668-79. PubMed ID: 18631348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antagonism between MyD88- and TRIF-dependent signals in B7RP-1 up-regulation.
    Zhou Z; Hoebe K; Du X; Jiang Z; Shamel L; Beutler B
    Eur J Immunol; 2005 Jun; 35(6):1918-27. PubMed ID: 15884053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-32gamma and Streptococcus pyogenes cell wall fragments synergise for IL-1-dependent destructive arthritis via upregulation of TLR-2 and NOD2.
    Heinhuis B; Koenders MI; van de Loo FA; van Lent PL; Kim SH; Dinarello CA; Joosten LA; van den Berg WB
    Ann Rheum Dis; 2010 Oct; 69(10):1866-72. PubMed ID: 20472585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonist.
    Lamacchia C; Palmer G; Seemayer CA; Talabot-Ayer D; Gabay C
    Arthritis Rheum; 2010 Feb; 62(2):452-62. PubMed ID: 20112392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1.
    Koenders MI; Lubberts E; Oppers-Walgreen B; van den Bersselaar L; Helsen MM; Di Padova FE; Boots AM; Gram H; Joosten LA; van den Berg WB
    Am J Pathol; 2005 Jul; 167(1):141-9. PubMed ID: 15972960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Critical role of TRIF and MyD88 in Mycobacterium tuberculosis Hsp70-mediated activation of dendritic cells.
    Kim TH; Shin SJ; Park YM; Jung ID; Ryu SW; Kim DJ; Park JH; Park JH
    Cytokine; 2015 Feb; 71(2):139-44. PubMed ID: 25461391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.